Enzon Pharmaceuticals's total assets for Q were $46.99M, an increase of 0.35% from the previous quarter. ENZN total liabilities were $410.00K for the fiscal quarter, a -21.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.